Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin Dosing in Plastic Surgery
NCT03212365Phase 2Completed
- Sponsor
- University of Utah
- Start
- Jul 2017
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin in venous thromboembolism (VTE), sponsored by University of Utah. Started Jul 2017; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03212365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03212365.